A new approach to mental health appears online. Within weeks, there are podcasts discussing it, TikTok videos documenting personal experiences, headlines calling it “promising”, and people saying it changed their lives.
Before long, something that was relatively unknown can start to feel established. This isn’t necessarily because people are gullible. It reflects something much more interesting about human psychology: our expectations, hopes, previous experiences, and social environment all influence how we interpret change.
Mental health makes this particularly complicated. Improvements in mood, motivation, anxiety, sleep, or well-being can be meaningful but difficult to measure objectively. At the same time, symptoms naturally fluctuate, and people often try several things at once.
So when someone feels better after starting something new, how do we know what actually made the difference? The answer is rarely as simple as it first appears.
We naturally look for cause and effect
Our brains are constantly searching for patterns. If we make a change and then feel different, connecting those two events makes intuitive sense. “I started doing X, and then I felt better. Therefore, X worked.”
Sometimes that conclusion may be correct. But there are other possibilities. Symptoms can change naturally over time. Someone may simultaneously improve their sleep, exercise more, change their diet, start therapy, reduce stress, or receive more social support. Simply deciding to address a problem can also change how closely we monitor our well-being.
Researchers have to account for these competing explanations when evaluating an intervention. That is one reason controlled studies matter. They help researchers ask whether improvements associated with an intervention are greater than changes that might occur for other reasons.
Expectations can influence what we experience
Expectation is one of the most fascinating variables in mental health research. If someone strongly expects an intervention to help, that expectation can influence how they interpret their experiences and report symptoms.
This is related to the placebo effect, but “placebo” shouldn’t be understood as meaning that someone is imagining their improvement. A systematic review and meta-analysis of placebo conditions in mental health research found evidence of improvement in placebo groups compared with passive controls, although the researchers cautioned that results varied between studies and some included studies had a high risk of bias.
Expectations can also shape attention. When people expect to feel calmer, more focused, or more energetic, they may become particularly alert to moments that confirm those expectations. This makes expectancy an important variable to study rather than something researchers can simply ignore.
New treatments arrive with a story
Some interventions arrive with powerful narratives already attached to them. They might be described as revolutionary, natural, futuristic, ancient, personalised, or completely different from conventional approaches.
Those stories matter. An intervention associated with cutting-edge neuroscience may create different expectations from one associated with traditional healing, even before either has been tried.
Social media can amplify these narratives dramatically. Thousands of personal accounts can create the impression that something is already well understood even when controlled research is still developing.
This doesn’t mean those experiences are meaningless. It means the cultural story surrounding an intervention can become part of what researchers need to consider when studying it.
Why placebo-controlled research matters
One of the fundamental questions in clinical research is whether an observed improvement can actually be attributed to the intervention being studied.
This is where placebo-controlled research becomes useful. Participants can be assigned to receive either an active intervention or an inactive comparison, ideally without knowing which they received. Researchers can then examine whether outcomes differ between groups. The approach becomes particularly interesting when participants can guess which group they are in.
If an intervention creates noticeable sensations, maintaining effective blinding can become difficult. Participants who correctly guess that they received the active intervention may develop stronger expectations about what should happen next.
Researchers studying psychedelic compounds have identified this as an important methodological challenge. A 2024 paper on expectancy effects in psychedelic trials discusses how participant expectations and difficulties maintaining blinding can complicate interpretation of trial results. Good research therefore doesn’t simply ask whether participants improved. It asks what else might explain the improvement.
Emerging research shows why expectations matter
This becomes especially relevant when an intervention already attracts strong public interest. Consider microdosing research. Anecdotal accounts have often associated psychedelic microdosing with changes in mood, creativity, focus, or wellbeing, but researchers have been investigating how much observed change can be separated from expectations surrounding the practice.
A prospective study examining expectations around psychedelic microdosing found that positive expectations at baseline predicted subsequent improvements in several self-reported outcomes. The researchers argued that this highlighted an important role for expectancy and cautioned against making strong therapeutic interpretations.
A double-blind, placebo-controlled study of psilocybin mushroom microdosing similarly found no evidence supporting enhanced wellbeing, creativity, or cognitive function on most of the measures examined, while suggesting expectations could account for some anecdotal benefits.
But the scientific picture isn’t as simple as saying “it’s all placebo”. A 2024 review of 19 placebo-controlled microdosing studies concluded that the existing evidence is not sufficient to determine whether microdosing effects are predominantly explained by placebo. The authors highlighted methodological limitations including small samples, limited doses, non-clinical populations, selection bias, and challenges around measuring expectancy.
That uncertainty is exactly why research continues. Science becomes stronger when competing explanations are tested rather than assumed.
Personal stories are powerful, but they answer a different question
If someone says a particular approach helped them, they may be describing their experience completely accurately. The limitation is not necessarily the story itself. It is what we conclude from it.
A personal account can answer: “What happened to this person?” It cannot reliably answer: “What usually happens when people receive this intervention?”
Answering the second question requires studying larger groups, comparing outcomes, controlling for alternative explanations, and ideally replicating findings independently. This distinction can be difficult because stories are psychologically powerful.
Statistics tell us what happened across a sample. Stories give us someone to identify with. When scrolling online, the person saying “this changed everything” may naturally feel more convincing than a research paper describing confidence intervals and methodological limitations. That emotional power doesn’t make the story false. It simply doesn’t transform it into controlled evidence.
We notice evidence that supports what we already believe
Another psychological process can enter the picture: confirmation bias. Once we believe something works, we tend to notice information that supports that belief more readily.
Imagine someone starts a new routine expecting better concentration. A highly productive Tuesday may feel like confirmation that the routine is working. A distracted Thursday might be blamed on poor sleep, stress, or an unusually busy day.
Without intending to, we can apply different explanations to evidence depending on whether it supports what we already believe. This is precisely why good experimental design tries to reduce the influence of expectations on both participants and researchers. Science doesn’t eliminate human bias. It creates systems designed to make those biases easier to detect.
“Promising” does not mean “proven”
Mental health headlines frequently use the word “promising”. Scientifically, promising can be perfectly reasonable. It might mean an early study produced results interesting enough to justify further investigation.
But online, “promising” can quickly become “effective”. Those aren’t equivalent. Early research may involve small samples, healthy volunteers rather than clinical populations, short follow-up periods, or findings that haven’t yet been replicated. Later studies can produce different results. That isn’t science changing its mind randomly. It is how knowledge becomes more reliable. The important question isn’t whether the first study was exciting. It is whether the finding continues to hold as researchers test it more rigorously.
Novelty makes us pay attention
There is another simple reason emerging approaches attract interest: new things are interesting. A familiar intervention that has been studied for decades doesn’t generate the same curiosity as a completely new technology or rediscovered compound.
Novelty attracts media attention, investment, discussion, and research. It can also create an unusual imbalance. We may hear far more about an experimental intervention precisely because it is experimental, while established approaches receive less attention because they are already familiar. Media visibility should therefore not be confused with scientific importance.
The intervention dominating your feed isn’t necessarily the one supported by the strongest evidence. Sometimes it is simply the one generating the most conversation.
Healthy scepticism doesn’t mean rejecting new ideas
It is easy to frame conversations about emerging mental health interventions as a battle between believers and sceptics. That misses the point. Scientific scepticism doesn’t require assuming that a new intervention doesn’t work. It means being willing to ask what evidence would demonstrate that it does, and being equally willing to consider evidence that challenges the original idea.
Some emerging approaches will eventually accumulate stronger evidence. Others won’t. And some will turn out to be useful only for particular people, conditions, doses, or circumstances. We usually can’t know which category something belongs to from early studies or enthusiastic testimonials alone.
Curiosity works best alongside critical thinking
There is nothing wrong with being excited about innovation in mental health. Psychology and neuroscience continue to evolve because researchers challenge assumptions and investigate new possibilities. But excitement works best when paired with good questions.
How large was the study? Was there a placebo or comparison group? Were participants blinded? Could they tell which intervention they received? Were expectations measured? Has another research team replicated the finding? Were the participants people with the condition being discussed? How long were they followed?
Those questions don’t make research less exciting. They help us understand what it actually tells us. The next time a headline announces a revolutionary new mental health intervention, curiosity is a reasonable response. Just leave room for another thought alongside it:
What else could explain what we’re seeing?
That question is not an obstacle to discovering better approaches to mental health. It is one of the tools that helps science determine which ideas genuinely deserve to move forward.
Adam Mulligan, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.